Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).
Cancers (Basel). 2024 May 8;16(10):1802. doi: 10.3390/cancers16101802.
Cancers (Basel). 2024.
PMID: 38791882
Free PMC article.
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Provenzano L, Lobefaro R, Ligorio F, Zattarin E, Zambelli L, Sposetti C, Presti D, Montelatici G, Ficchì A, Martinetti A, Arata A, Del Vecchio M, Lauria Pantano C, Formisano B, Bianchi GV, Capri G, de Braud F, Vernieri C, Fucà G.
Provenzano L, et al. Among authors: lauria pantano c.
Ther Adv Med Oncol. 2023 Apr 13;15:17588359231165978. doi: 10.1177/17588359231165978. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37063779
Free PMC article.
Item in Clipboard
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
Fucà G, Beninato T, Bini M, Mazzeo L, Di Guardo L, Cimminiello C, Randon G, Apollonio G, Bisogno I, Del Vecchio M, Lauria Pantano C, Di Nicola M, de Braud F, Del Vecchio M.
Fucà G, et al. Among authors: lauria pantano c.
Target Oncol. 2021 Jul;16(4):529-536. doi: 10.1007/s11523-021-00819-0. Epub 2021 Jun 2.
Target Oncol. 2021.
PMID: 34076798
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.